Octreotide (OCT)—which is a first-generation SSA—modulates cytokine production in rheumatoid arthritis synoviocytes through interleukin-15 and TNF-α inhibition and increases interleukin-10 levels [34]. Here, TNF is linked to rheumatoid arthritis.